| Somatic mutations of calreticulin in myeloproliferative neoplasms T Klampfl, H Gisslinger, AS Harutyunyan, H Nivarthi, E Rumi, JD Milosevic, ... New England Journal of Medicine 369 (25), 2379-2390, 2013 | 2593 | 2013 |
| LZTR1 is a regulator of RAS ubiquitination and signaling JW Bigenzahn, GM Collu, F Kartnig, M Pieraks, GI Vladimer, LX Heinz, ... Science 362 (6419), 1171-1177, 2018 | 241 | 2018 |
| Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells DA Lichtenstein, F Schischlik, L Shao, SM Steinberg, B Yates, HW Wang, ... Blood, The Journal of the American Society of Hematology 138 (24), 2469-2484, 2021 | 184 | 2021 |
| A reversible gene trap collection empowers haploid genetics in human cells T Bürckstümmer, C Banning, P Hainzl, R Schobesberger, C Kerzendorfer, ... Nature methods 10 (10), 965-971, 2013 | 121 | 2013 |
| MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation S Sdelci, AF Rendeiro, P Rathert, W You, JMG Lin, A Ringler, G Hofstätter, ... Nature genetics 51 (6), 990-998, 2019 | 91 | 2019 |
| Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms F Schischlik, R Jäger, F Rosebrock, E Hug, M Schuster, R Holly, E Fuchs, ... Blood, The Journal of the American Society of Hematology 134 (2), 199-210, 2019 | 79 | 2019 |
| Deconvolving clinically relevant cellular immune cross-talk from bulk gene expression using CODEFACS and LIRICS stratifies patients with melanoma to anti–PD-1 therapy K Wang, S Patkar, JS Lee, EM Gertz, W Robinson, F Schischlik, ... Cancer discovery 12 (4), 1088-1105, 2022 | 62 | 2022 |
| Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia K Kapralova, M Horvathova, C Pecquet, J Fialova Kucerova, ... Blood, The Journal of the American Society of Hematology 128 (10), 1418-1423, 2016 | 62 | 2016 |
| Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemia M Moder, G Velimezi, M Owusu, A Mazouzi, M Wiedner, ... Nature communications 8 (1), 1238, 2017 | 41 | 2017 |
| Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking A Fauster, M Rebsamen, KL Willmann, A César-Razquin, E Girardi, ... Cell Death & Differentiation 26 (6), 1138-1155, 2019 | 39 | 2019 |
| Mutations in myeloproliferative neoplasms–their significance and clinical use F Schischlik, R Kralovics Expert review of hematology 10 (11), 961-973, 2017 | 35 | 2017 |
| CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity J Jess, B Yates, A Dulau-Florea, K Parker, J Inglefield, D Lichtenstein, ... Journal for Immunotherapy of Cancer 11 (6), e005898, 2023 | 31 | 2023 |
| The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective S Ahmadi, P Sukprasert, R Vegesna, S Sinha, F Schischlik, N Artzi, ... Nature communications 13 (1), 1613, 2022 | 28 | 2022 |
| Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera R Jäger, H Gisslinger, E Fuchs, E Bogner, JD Milosevic Feenstra, ... Blood, The Journal of the American Society of Hematology 137 (3), 387-391, 2021 | 23 | 2021 |
| PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms JD Milosevic Feenstra, R Jäger, F Schischlik, D Ivanov, G Eisenwort, ... American Journal of Hematology 97 (4), 390-400, 2022 | 22 | 2022 |
| Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification A Tedeschi, F Schischlik, F Rocchetti, J Popow, F Ebner, D Gerlach, ... Molecular Cancer Therapeutics 24 (4), 550-562, 2025 | 16 | 2025 |
| Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes W Robinson, JK Stone, F Schischlik, B Gasmi, MC Kelly, C Seibert, ... Science advances 10 (27), eadj7402, 2024 | 15 | 2024 |
| Transcriptional control of leukemogenesis by the chromatin reader SGF29 K Barbosa, A Deshpande, M Perales, P Xiang, R Murad, AB Pramod, ... Blood 143 (8), 697-712, 2024 | 15 | 2024 |
| KRASmulti inhibitor BI 3706674 shows efficacy in KRAS-driven preclinical models of cancer that supports clinical testing in patients with tumors harbouring KRASG12V mutations … A Tedeschi, DH Peng, F Schischlik, L Herdeis, O Schaaf, V Santoro, ... Cancer Research 84 (6_Supplement), 3317-3317, 2024 | 11 | 2024 |
| CSI-Microbes: Identifying cell-type specific intracellular microbes from single-cell RNA-seq data W Robinson, F Schischlik, EM Gertz, JS Lee, K Zhu, SC Sahinalp, R Patro, ... bioRxiv, 2021 | 11* | 2021 |
